BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT04249622-completion@plaintrial.com
DTSTAMP:20260928T015742Z
DTSTART;VALUE=DATE:20221227
SUMMARY:Rifaximin for the Treatment of Gastrointestinal Toxicities Related 
 to Pertuzumab-Based Therapy in Patients With Stage I-III HER2 Positive Bre
 ast Cancer — estimated completion date
DESCRIPTION:Terminated. Saved on your PlainTrial shortlist. Full trial reco
 rd: https://plaintrial.com/trial/NCT04249622
URL:https://plaintrial.com/trial/NCT04249622
END:VEVENT
END:VCALENDAR